Vietnam Meningococcal Vaccines Market Report 2022 to 2030

Vietnam Meningococcal Vaccines Market Analysis

$ 3999

Vietnam meningococcal vaccines market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of meningococcal disease among young children and adolescents globally is one of the key factors driving the market's rise. Additionally, market expansion is being fueled by the acceptance of routine vaccinations and an overall rise in health consciousness. The major key players in this market are GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.

ID: IN10VNPH333 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Saloni Shah

Buy Now

Vietnam Meningococcal Vaccines Market Analysis Summary

Vietnam Meningococcal Vaccines Market is valued at around $19.8 Mn in 2022 and is projected to reach $37.1 Mn by 2030, exhibiting a CAGR of 8.19% during the forecast period 2023-2030.

The meningococcal vaccination is a biological agent used to prevent meningitis, a deadly condition affecting the membranes that surround the spinal cord and brain. The three primary forms of meningococcal vaccinations are conjugate, polysaccharide, and subcapsular. They are administered to infants, children, and adults to immunise them against the invasive disease and target the meningococcal bacteria A, B, C, W-135, and Y. The body responds to the vaccination by producing antibodies that fight the bacteria and trigger an immunological response that will help the body fight off future illnesses. The long-term symptoms of the disease, which can include neurological impairment, seizures, loss of vision or motor skills, and temporary or permanent hearing loss, are lessened by the meningococcal vaccine. As a result, governments in both developed and developing nations are launching extensive public health campaigns with a focus on immunising certain risk populations, such tourists and members of the military forces, to lower the chance of infections. One example of a product innovation that is assisting the market's growth is the development of ready-to-use liquid formulations that don't require reconstitution. The market is expected to be further fueled by additional factors including extensive Research and Development (R&D) initiatives and improvements in the healthcare infrastructure. The increasing incidence of meningococcal disease among young children and adolescents globally is one of the key factors driving the market's rise. Additionally, market expansion is being fueled by the acceptance of routine vaccinations and an overall rise in health consciousness. The major key players in this market are GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.

Market Dynamics

Market Growth Drivers

The main element fueling market expansion is the rising prevalence of meningococcal diseases worldwide. Various government awareness campaigns aim to raise awareness about vaccination in order to reduce the effects of illnesses. During the forecast period, higher R&D expenditures for meningococcal vaccine development are anticipated to fuel market expansion.

Market Restraints

However, the high cost of vaccine development and the strict regulatory approval process are projected to restrain market expansion.

Competitive Landscape

Key Players

GlaxoSmithKline Plc
Hualan Biological Engineering Inc.
Incepta Pharmaceuticals Ltd.
Novartis AG
Pfizer Inc.
Sanofi S.A.
Serum Institute of India Ltd.
Walvax Biotechnology Co. Ltd.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Meningococcal Vaccines Market Segmentation

By Vaccine Serotype

MenACWY
MenB & Manic
MenC
MenA
MenAC

By Vaccine Type

Conjugate
Polysaccharide
Subcapsular

By End Users

Pediatric
Adult
Travellers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.